Global Opioid-Induced Constipation Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Report ID: GIR2106040145 | Category: Pharma & Healthcare | Pages: 104 | Format: PDF | Published Date: October 22,2021

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Opioid-Induced Constipation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Opioid-Induced Constipation size is estimated to be XX million in 2021 from USD 2484.9 million in 2020, with a change of XX% between 2020 and 2021. The global Opioid-Induced Constipation market size is expected to grow at a CAGR of 4.4% for the next five years.

Market segmentation
Opioid-Induced Constipation market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Methylnaltrexone Bromide
    Lubiprostone
    Naloxegol
    Others

Market segment by Application can be divided into
    Hospital
    Pharmacy
    Other

The key market players for global Opioid-Induced Constipation market are listed below:
    Takeda Pharmaceuticals
    Bayer
    Sanofi
    Mallinckrodt
    Salix (Bausch Health)
    AstraZeneca
    Progenics Pharmaceuticals
    Purdue Pharm
    Nektar Therapeutics
    Daiichi Sankyo
    Prestige
    GSK
    Shionogi

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Opioid-Induced Constipation product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioid-Induced Constipation, with price, sales, revenue and global market share of Opioid-Induced Constipation from 2019 to 2021.
Chapter 3, the Opioid-Induced Constipation competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioid-Induced Constipation breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Opioid-Induced Constipation market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Opioid-Induced Constipation sales channel, distributors, customers, research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Opioid-Induced Constipation Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Opioid-Induced Constipation Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Methylnaltrexone Bromide
        1.2.3 Lubiprostone
        1.2.4 Naloxegol
        1.2.5 Others
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Opioid-Induced Constipation Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Hospital
        1.3.3 Pharmacy
        1.3.4 Other
    1.4 Global Opioid-Induced Constipation Market Size & Forecast
        1.4.1 Global Opioid-Induced Constipation Sales in Value (2016-2026))
        1.4.2 Global Opioid-Induced Constipation Sales in Volume (2016-2026)
        1.4.3 Global Opioid-Induced Constipation Price by Type (2016-2026) & (USD/Unit)
    1.5 Global Opioid-Induced Constipation Production Capacity Analysis
        1.5.1 Global Opioid-Induced Constipation Total Production Capacity (2016-2026)
        1.5.2 Global Opioid-Induced Constipation Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Opioid-Induced Constipation Market Drivers
        1.6.2 Opioid-Induced Constipation Market Restraints
        1.6.3 Opioid-Induced Constipation Trends Analysis
2 Manufacturers Profiles
    2.1 Takeda Pharmaceuticals
        2.1.1 Takeda Pharmaceuticals Details
        2.1.2 Takeda Pharmaceuticals Major Business
        2.1.3 Takeda Pharmaceuticals Opioid-Induced Constipation Product and Services
        2.1.4 Takeda Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Bayer
        2.2.1 Bayer Details
        2.2.2 Bayer Major Business
        2.2.3 Bayer Opioid-Induced Constipation Product and Services
        2.2.4 Bayer Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Sanofi
        2.3.1 Sanofi Details
        2.3.2 Sanofi Major Business
        2.3.3 Sanofi Opioid-Induced Constipation Product and Services
        2.3.4 Sanofi Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Mallinckrodt
        2.4.1 Mallinckrodt Details
        2.4.2 Mallinckrodt Major Business
        2.4.3 Mallinckrodt Opioid-Induced Constipation Product and Services
        2.4.4 Mallinckrodt Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Salix (Bausch Health)
        2.5.1 Salix (Bausch Health) Details
        2.5.2 Salix (Bausch Health) Major Business
        2.5.3 Salix (Bausch Health) Opioid-Induced Constipation Product and Services
        2.5.4 Salix (Bausch Health) Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 AstraZeneca
        2.6.1 AstraZeneca Details
        2.6.2 AstraZeneca Major Business
        2.6.3 AstraZeneca Opioid-Induced Constipation Product and Services
        2.6.4 AstraZeneca Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 Progenics Pharmaceuticals
        2.7.1 Progenics Pharmaceuticals Details
        2.7.2 Progenics Pharmaceuticals Major Business
        2.7.3 Progenics Pharmaceuticals Opioid-Induced Constipation Product and Services
        2.7.4 Progenics Pharmaceuticals Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 Purdue Pharm
        2.8.1 Purdue Pharm Details
        2.8.2 Purdue Pharm Major Business
        2.8.3 Purdue Pharm Opioid-Induced Constipation Product and Services
        2.8.4 Purdue Pharm Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 Nektar Therapeutics
        2.9.1 Nektar Therapeutics Details
        2.9.2 Nektar Therapeutics Major Business
        2.9.3 Nektar Therapeutics Opioid-Induced Constipation Product and Services
        2.9.4 Nektar Therapeutics Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.10 Daiichi Sankyo
        2.10.1 Daiichi Sankyo Details
        2.10.2 Daiichi Sankyo Major Business
        2.10.3 Daiichi Sankyo Opioid-Induced Constipation Product and Services
        2.10.4 Daiichi Sankyo Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.11 Prestige
        2.11.1 Prestige Details
        2.11.2 Prestige Major Business
        2.11.3 Prestige Opioid-Induced Constipation Product and Services
        2.11.4 Prestige Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.12 GSK
        2.12.1 GSK Details
        2.12.2 GSK Major Business
        2.12.3 GSK Opioid-Induced Constipation Product and Services
        2.12.4 GSK Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.13 Shionogi
        2.13.1 Shionogi Details
        2.13.2 Shionogi Major Business
        2.13.3 Shionogi Opioid-Induced Constipation Product and Services
        2.13.4 Shionogi Opioid-Induced Constipation Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Opioid-Induced Constipation Sales by Manufacturer
    3.1 Global Opioid-Induced Constipation Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Opioid-Induced Constipation Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Opioid-Induced Constipation
    3.4 Market Concentration Rate
        3.4.1 Top 3 Opioid-Induced Constipation Manufacturer Market Share
        3.4.2 Top 6 Opioid-Induced Constipation Manufacturer Market Share
    3.5 Global Opioid-Induced Constipation Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Opioid-Induced Constipation Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Opioid-Induced Constipation Market Size by Region
        4.1.1 Global Opioid-Induced Constipation Sales in Volume by Region (2016-2026)
        4.1.2 Global Opioid-Induced Constipation Revenue by Region (2016-2026)
    4.2 North America Opioid-Induced Constipation Revenue (2016-2026)
    4.3 Europe Opioid-Induced Constipation Revenue (2016-2026)
    4.4 Asia-Pacific Opioid-Induced Constipation Revenue (2016-2026)
    4.5 South America Opioid-Induced Constipation Revenue (2016-2026)
    4.6 Middle East and Africa Opioid-Induced Constipation Revenue (2016-2026)
5 Market Segment by Type
    5.1 Global Opioid-Induced Constipation Sales in Volume by Type (2016-2026)
    5.2 Global Opioid-Induced Constipation Revenue by Type (2016-2026)
    5.3 Global Opioid-Induced Constipation Price by Type (2016-2026)
6 Market Segment by Application
    6.1 Global Opioid-Induced Constipation Sales in Volume by Application (2016-2026)
    6.2 Global Opioid-Induced Constipation Revenue by Application (2016-2026)
    6.3 Global Opioid-Induced Constipation Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
    7.1 North America Opioid-Induced Constipation Sales by Type (2016-2026)
    7.2 North America Opioid-Induced Constipation Sales by Application (2016-2026)
    7.3 North America Opioid-Induced Constipation Market Size by Country
        7.3.1 North America Opioid-Induced Constipation Sales in Volume by Country (2016-2026)
        7.3.2 North America Opioid-Induced Constipation Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
    8.1 Europe Opioid-Induced Constipation Sales by Type (2016-2026)
    8.2 Europe Opioid-Induced Constipation Sales by Application (2016-2026)
    8.3 Europe Opioid-Induced Constipation Market Size by Country
        8.3.1 Europe Opioid-Induced Constipation Sales in Volume by Country (2016-2026)
        8.3.2 Europe Opioid-Induced Constipation Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Opioid-Induced Constipation Sales by Type (2016-2026)
    9.2 Asia-Pacific Opioid-Induced Constipation Sales by Application (2016-2026)
    9.3 Asia-Pacific Opioid-Induced Constipation Market Size by Region
        9.3.1 Asia-Pacific Opioid-Induced Constipation Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Opioid-Induced Constipation Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
    10.1 South America Opioid-Induced Constipation Sales by Type (2016-2026)
    10.2 South America Opioid-Induced Constipation Sales by Application (2016-2026)
    10.3 South America Opioid-Induced Constipation Market Size by Country
        10.3.1 South America Opioid-Induced Constipation Sales in Volume by Country (2016-2026)
        10.3.2 South America Opioid-Induced Constipation Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Opioid-Induced Constipation Sales by Type (2016-2026)
    11.2 Middle East & Africa Opioid-Induced Constipation Sales by Application (2016-2026)
    11.3 Middle East & Africa Opioid-Induced Constipation Market Size by Country
        11.3.1 Middle East & Africa Opioid-Induced Constipation Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Opioid-Induced Constipation Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Opioid-Induced Constipation Typical Distributors
    12.3 Opioid-Induced Constipation Typical Customers
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Opioid-Induced Constipation Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?